Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Bone
|
January 17, 2012
Effects of Src kinase inhibition by saracatinib (AZD0530) on bone turnover in advanced malignancy in a Phase I study
Rosemary A Hannon, Richard D Finkelman, Glen Clack, et al.
Clinical Endocrinology
|
August 2, 2018
Effect of vitamin D supplementation on free and total vitamin D: A comparison of Asians and Caucasians
Jaya Sujatha Gopal-Kothandapani, Lucy Faith Evans, Jennifer S Walsh, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 25, 2018
Effect of Teriparatide Treatment on Circulating Periostin and Its Relationship to Regulators of Bone Formation and BMD in Postmenopausal Women With Osteoporosis
Fatma Gossiel, Jessica R Scott, Margaret A Paggiosi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 12, 2022
Long-Term Selenium-Yeast Supplementation Does Not Affect Bone Turnover Markers: A Randomized Placebo-Controlled Trial
Giorgia Perri, Tom R Hill, John C Mathers, et al.
The Lancet. Oncology
|
December 3, 2014
Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial
Ivana Sestak, Shalini Singh, Jack Cuzick, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 23, 2014
Oxytocin, a new determinant of bone mineral density in post-menopausal women: analysis of the OPUS cohort
Véronique Breuil, Patricia Panaia-Ferrari, Eric Fontas, et al.
Journal of the National Cancer Institute
|
February 10, 2018
Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial
Janet Brown, Emma Rathbone, Samantha Hinsley, et al.
Journal of Endocrinological Investigation
|
July 7, 2025
Dose-dependent and tissue-specific adverse effects of exogenous glucocorticoids: insights for optimizing clinical practice
Riccardo Pofi, Nantia Othonos, Thomas Marjot, et al.
The American Journal of Clinical Nutrition
|
July 23, 2021
Bone turnover in pregnancy, measured by urinary CTX, is influenced by vitamin D supplementation and is associated with maternal bone health: findings from the Maternal Vitamin D Osteoporosis Study (MAVIDOS) trial
Elizabeth M Curtis, Camille Parsons, Kate Maslin, et al.
The New England Journal of Medicine
|
June 30, 2016
Cortical-Bone Fragility--Insights from sFRP4 Deficiency in Pyle's Disease
Pelin O Simsek Kiper, Hiroaki Saito, Francesca Gori, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Bone
|
January 17, 2012
Effects of Src kinase inhibition by saracatinib (AZD0530) on bone turnover in advanced malignancy in a Phase I study
Rosemary A Hannon, Richard D Finkelman, Glen Clack, et al.
Clinical Endocrinology
|
August 2, 2018
Effect of vitamin D supplementation on free and total vitamin D: A comparison of Asians and Caucasians
Jaya Sujatha Gopal-Kothandapani, Lucy Faith Evans, Jennifer S Walsh, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 25, 2018
Effect of Teriparatide Treatment on Circulating Periostin and Its Relationship to Regulators of Bone Formation and BMD in Postmenopausal Women With Osteoporosis
Fatma Gossiel, Jessica R Scott, Margaret A Paggiosi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 12, 2022
Long-Term Selenium-Yeast Supplementation Does Not Affect Bone Turnover Markers: A Randomized Placebo-Controlled Trial
Giorgia Perri, Tom R Hill, John C Mathers, et al.
The Lancet. Oncology
|
December 3, 2014
Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial
Ivana Sestak, Shalini Singh, Jack Cuzick, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 23, 2014
Oxytocin, a new determinant of bone mineral density in post-menopausal women: analysis of the OPUS cohort
Véronique Breuil, Patricia Panaia-Ferrari, Eric Fontas, et al.
Journal of the National Cancer Institute
|
February 10, 2018
Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial
Janet Brown, Emma Rathbone, Samantha Hinsley, et al.
Journal of Endocrinological Investigation
|
July 7, 2025
Dose-dependent and tissue-specific adverse effects of exogenous glucocorticoids: insights for optimizing clinical practice
Riccardo Pofi, Nantia Othonos, Thomas Marjot, et al.
The American Journal of Clinical Nutrition
|
July 23, 2021
Bone turnover in pregnancy, measured by urinary CTX, is influenced by vitamin D supplementation and is associated with maternal bone health: findings from the Maternal Vitamin D Osteoporosis Study (MAVIDOS) trial
Elizabeth M Curtis, Camille Parsons, Kate Maslin, et al.
The New England Journal of Medicine
|
June 30, 2016
Cortical-Bone Fragility--Insights from sFRP4 Deficiency in Pyle's Disease
Pelin O Simsek Kiper, Hiroaki Saito, Francesca Gori, et al.
Page
of 5